Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 19 results

Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study

research Effectiveness of Baricitinib for Nasal, Genital, and Beard Hair Regrowth in Patients with Severe Alopecia Areata: 12-Month Outcomes from a Prospective Observational Study

November 2025 in “SKIN The Journal of Cutaneous Medicine”

Baricitinib significantly regrows hair in nasal, genital, and beard areas for severe alopecia areata.

research Gene Variant in Amish a Clue to Better Aging

January 2018 in “Genetic engineering & biotechnology news”

A genetic mutation linked to longer life and less disease was found in the Amish, and a drug is being developed to replicate these benefits.

research First-In-Human Clinical Trial Evaluating AI-09, A Novel Long-Lasting Ready-To-Use Liquid Injectable Neuromodulator For The Treatment Of Glabellar Lines

July 2025 in “Journal of Investigative Dermatology”

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

research Comparison of Two ASC-Derived Therapeutics in an In Vitro Osteoarthritis Model: Secretome Versus Extracellular Vesicles

60 citations , December 2020 in “Stem Cell Research & Therapy”

ASC-CM is more effective than EV for treating osteoarthritis.

research Advances in Nucleoside Monophosphate Prodrugs as Anti-HCV Agents

52 citations , October 2010 in “Antiviral Therapy”

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

View more "eirion therapeutics" in research →

Community Join

5 / 17 results

community Eirion Therapeutics Announces Potential Breakthrough Treatment for Hair Loss Based on First-in-Man Clinical Trial Results

in Update 415 upvotes 1 year ago

ET-02, a new hair loss treatment, shows promising results with a 6-fold increase in hair count, potentially outperforming minoxidil by activating stem cells in hair follicles. Further trials are ongoing to confirm its efficacy and safety, with potential market release in the future.

community ET-02 Now Recruiting in Texas for Phase 1

in Research/Science 20 upvotes 1 year ago

Eirion Therapeutics is recruiting for phase 1 of ET-02 in Texas, which showed promising hair growth results in non-clinical studies. ET-02 demonstrated significantly more hair growth compared to Minoxidil.

community What new hair-loss treatments actually look exciting right now (Oct 2025)

in Research/Science 172 upvotes 3 months ago

New hair loss treatments include Breezula, PP405, ET-02, KX-826, GT20029, VDPHL01, and CosmeRNA, with some showing promise in reactivating stem cells and reversing greying. Breezula and VDPHL01 are highlighted as potential add-ons or alternatives to current treatments like finasteride and minoxidil.

community Status update on upcoming treatments

in Treatment 51 upvotes 9 months ago

Current treatments like finasteride, minoxidil, and derma rolling are considered the best for hair loss, while new treatments such as GT20029, PP405, and others are in various trial phases with results expected in the coming years. There is cautious optimism about the affordability and effectiveness of these upcoming treatments.

community Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases

in Research/Science 35 upvotes 1 year ago

Finasteride, Minoxidil, Bioneer CosmeRNA, Technoderma, Kintor, Hope, Breezula, and Follicum treatments showed increases in hair count, with Technoderma showing the highest increase at 24.3 hairs/cm². Amplifica has not yet published results.

View more "eirion therapeutics" in community →